These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1125 related articles for article (PubMed ID: 29690669)
1. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells]. Yan ZY; Sun XC Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669 [No Abstract] [Full Text] [Related]
2. Endogenous miRNA sponge lincRNA-RoR regulates Oct4, Nanog, and Sox2 in human embryonic stem cell self-renewal. Wang Y; Xu Z; Jiang J; Xu C; Kang J; Xiao L; Wu M; Xiong J; Guo X; Liu H Dev Cell; 2013 Apr; 25(1):69-80. PubMed ID: 23541921 [TBL] [Abstract][Full Text] [Related]
3. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma. Bourguignon LY; Wong G; Earle C; Chen L J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005 [TBL] [Abstract][Full Text] [Related]
4. ROR functions as a ceRNA to regulate Nanog expression by sponging miR-145 and predicts poor prognosis in pancreatic cancer. Gao S; Wang P; Hua Y; Xi H; Meng Z; Liu T; Chen Z; Liu L Oncotarget; 2016 Jan; 7(2):1608-18. PubMed ID: 26636540 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-598 inhibits the growth and maintenance of gastric cancer stem-like cells by down-regulating RRS1. Ma Y; Yan F; Wei W; Deng J; Li L; Liu L; Sun J Cell Cycle; 2019 Oct; 18(20):2757-2769. PubMed ID: 31438772 [TBL] [Abstract][Full Text] [Related]
6. Acquisition cancer stemness, mesenchymal transdifferentiation, and chemoresistance properties by chronic exposure of oral epithelial cells to arecoline. Wang TY; Peng CY; Lee SS; Chou MY; Yu CC; Chang YC Oncotarget; 2016 Dec; 7(51):84072-84081. PubMed ID: 27557511 [TBL] [Abstract][Full Text] [Related]
7. Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression. Fu TY; Hsieh IC; Cheng JT; Tsai MH; Hou YY; Lee JH; Liou HH; Huang SF; Chen HC; Yen LM; Tseng HH; Ger LP J Oral Pathol Med; 2016 Feb; 45(2):89-95. PubMed ID: 26211876 [TBL] [Abstract][Full Text] [Related]
8. Expression of SOX2, NANOG and OCT4 in a mouse model of lipopolysaccharide-induced acute uterine injury and intrauterine adhesions. Xiao L; Song Y; Huang W; Yang S; Fu J; Feng X; Zhou M Reprod Biol Endocrinol; 2017 Mar; 15(1):14. PubMed ID: 28253866 [TBL] [Abstract][Full Text] [Related]
9. Correlation of Cancer Stem-Cell Markers OCT4, SOX2, and NANOG with Clinicopathological Features and Prognosis in Operative Patients with Rectal Cancer. You L; Guo X; Huang Y Yonsei Med J; 2018 Jan; 59(1):35-42. PubMed ID: 29214774 [TBL] [Abstract][Full Text] [Related]
10. Curcumin suppresses proliferation and in vitro invasion of human prostate cancer stem cells by ceRNA effect of miR-145 and lncRNA-ROR. Liu T; Chi H; Chen J; Chen C; Huang Y; Xi H; Xue J; Si Y Gene; 2017 Oct; 631():29-38. PubMed ID: 28843521 [TBL] [Abstract][Full Text] [Related]
11. LncRNA LOC100507144 acts as a novel regulator of CD44/Nanog/Sox2/miR-302/miR-21 axis in colorectal cancer. Ebrahimi N; Rezanejad H; Asadi MH; Vallian S Biofactors; 2022 Jan; 48(1):164-180. PubMed ID: 34882869 [TBL] [Abstract][Full Text] [Related]
12. Comparison of Cellular Transforming Activity of OCT4, NANOG, and SOX2 in Immortalized Astrocytes. Seo S; Jeon HY; Kim H DNA Cell Biol; 2017 Nov; 36(11):1000-1009. PubMed ID: 28933914 [TBL] [Abstract][Full Text] [Related]
13. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells. Alberti L; Losi L; Leyvraz S; Benhattar J PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996 [TBL] [Abstract][Full Text] [Related]
14. MicroR-760 suppresses cancer stem cell subpopulation and breast cancer cell proliferation and metastasis: By down-regulating NANOG. Han ML; Wang F; Gu YT; Pei XH; Ge X; Guo GC; Li L; Duan X; Zhu MZ; Wang YM Biomed Pharmacother; 2016 May; 80():304-310. PubMed ID: 27133070 [TBL] [Abstract][Full Text] [Related]
15. Protein arginine methyltransferase 7-mediated Chen TY; Lee SH; Dhar SS; Lee MG J Biol Chem; 2018 Mar; 293(11):3925-3936. PubMed ID: 29378844 [TBL] [Abstract][Full Text] [Related]
16. Crosstalks between Raf-kinase inhibitor protein and cancer stem cell transcription factors (Oct4, KLF4, Sox2, Nanog). Lee S; Wottrich S; Bonavida B Tumour Biol; 2017 Apr; 39(4):1010428317692253. PubMed ID: 28378634 [TBL] [Abstract][Full Text] [Related]
17. Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas. Guo Y; Liu S; Wang P; Zhao S; Wang F; Bing L; Zhang Y; Ling EA; Gao J; Hao A Histopathology; 2011 Oct; 59(4):763-75. PubMed ID: 22014056 [TBL] [Abstract][Full Text] [Related]
18. Long Non-Coding RNA lincRNA-ROR Promotes the Progression of Colon Cancer and Holds Prognostic Value by Associating with miR-145. Zhou P; Sun L; Liu D; Liu C; Sun L Pathol Oncol Res; 2016 Oct; 22(4):733-40. PubMed ID: 27071407 [TBL] [Abstract][Full Text] [Related]
19. FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells. Choi EJ; Seo EJ; Kim DK; Lee SI; Kwon YW; Jang IH; Kim KH; Suh DS; Kim JH Oncotarget; 2016 Jan; 7(3):3506-19. PubMed ID: 26654944 [TBL] [Abstract][Full Text] [Related]
20. Relative Expression of OCT4, SOX2 and NANOG in Oral Squamous Cell Carcinoma Versus Adjacent Non- Tumor Tissue. Baghai Naini F; Aminishakib P; Abdollahi A; Hodjat M; Mohammadpour H; Kardouni Khoozestani N Asian Pac J Cancer Prev; 2019 Jun; 20(6):1649-1654. PubMed ID: 31244283 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]